Today: 20 May 2026
Strategy (MSTR) drops after-hours as bitcoin stays weak and fresh share sales hang over the stock
31 December 2025
2 mins read

Strategy (MSTR) drops after-hours as bitcoin stays weak and fresh share sales hang over the stock

NEW YORK, December 31, 2025, 16:43 ET — After-hours

  • Strategy shares slid 2.3% in after-hours trading, hovering near the day’s lows.
  • A recent SEC filing showed the company sold stock and used the proceeds to buy more bitcoin.
  • Traders are watching bitcoin’s direction into 2026 and whether Strategy keeps tapping its share-sale program.

Strategy Inc shares fell 2.3% to $151.95 in after-hours trade on Wednesday, after swinging between $151.44 and $157.48 earlier in the day. Trading volume topped 15.6 million shares.

The move matters because Strategy has become one of the market’s most visible “bitcoin proxy” stocks — an equity that tends to move with the cryptocurrency — at a time when investors are recalibrating their risk appetite into year-end.

Bitcoin is on track for its first yearly loss since 2022, after struggling to recover from an October peak above $126,000, Reuters reported. “Bitcoin increasingly exhibits the characteristics of a risk asset … with a notable correlation to the U.S. equity market,” Linh Tran, a senior market analyst at XS.com, said in the report. Reuters

In a Dec. 29 filing, Strategy disclosed it sold 663,450 Class A shares for $108.8 million in net proceeds and used the money to buy 1,229 bitcoin at an average price of about $88,568 each. The company said it held 672,497 bitcoin as of Dec. 28, bought for $50.44 billion in total at an average price of $74,997, and had about $11.7 billion still available for issuance under its common-stock sales program.

That sales program is known as an at-the-market offering, or ATM — a mechanism that lets a company sell new shares into the market over time. For existing shareholders, repeated issuance can be dilutive, meaning it spreads ownership across a larger share count.

At bitcoin’s recent levels, Strategy’s disclosed holdings are worth roughly $59 billion, leaving the stock highly sensitive to day-to-day moves in the token as well as shifts in investor tolerance for leverage and dilution.

The feedback loop cuts both ways. When bitcoin rises, Strategy’s ability to raise fresh equity can expand; when the token weakens, the market can push back on additional share sales, tightening the company’s room to maneuver.

Strategy describes itself as a “Bitcoin Treasury Company,” a label for firms that hold bitcoin as a core balance-sheet asset rather than a side investment. Strategy

That positioning has pulled the stock closer to crypto market plumbing than to the software business that originally defined MicroStrategy, the name Strategy used before its rebrand.

Traders also flag round-number levels after Wednesday’s slide. The $150 area is in focus after the stock probed just above it, while the mid-$150s mark the zone the shares struggled to hold into the close.

Next up, investors will watch for the company’s next disclosures around bitcoin purchases and equity issuance, along with any follow-through in the token as markets turn the calendar to 2026.

Strategy is estimated to report earnings on Feb. 4, according to Nasdaq.

For now, the stock’s after-hours drop underscored the same dynamic that has defined recent months: Strategy trades less like a conventional software name and more like a levered bet on bitcoin’s next move.

Stock Market Today

  • Euronext Q1 2026 Sees Record Trading Volumes and 15.3% Revenue Growth
    May 20, 2026, 5:43 AM EDT. Euronext reported a record Q1 2026 with cash equity trading and clearing revenue up 30.8% to €123 million, driven by high market volatility and the full contribution from Euronext Athens. Total underlying revenue rose 15.3% to €528.5 million, marking the exchange's eighth consecutive quarter of double-digit growth. Average daily cash equity transaction value in April reached €16.4 billion, with a 64.1% market share. Commodities trading revenue climbed 13.9%, while FX revenue grew 5.8%. ETF trading surged 84% since September 2025, boosted by the launch of mini ETF options. Adjusted EBITDA rose 16.7% to €343.2 million, with net income up 17.7%. Euronext declared a €3.18 dividend per share, reflecting a 50% payout, payable in May.

Latest articles

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

Co-Diagnostics Stock Surges — Then $3 Million Financing Puts The Rally To The Test

20 May 2026
New York, May 20, 2026, 05:08 EDT Co-Diagnostics shares face an early test on Wednesday after the diagnostic-test developer announced a $3 million private placement hours after its stock closed up 43.8% at $1.97 on Tuesday. Extended-hours trading showed the shares down 13.3% at $1.71 before the regular Nasdaq session. The timing matters. Co-Diagnostics had rallied after saying it had completed a strategy to develop an assay, or diagnostic test, for the Bundibugyo virus behind a fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda. The late financing then shifted attention to dilution and cash needs. The company said
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop